$ELAN
Elanco Animal Health Inc

2022 Q1 Form 10-Q Financial Statement

#000173910422000010 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $1.225B $1.242B
YoY Change -1.37% 88.75%
Cost Of Revenue $509.0M $569.0M
YoY Change -10.54% 70.87%
Gross Profit $716.0M $673.0M
YoY Change 6.39% 107.08%
Gross Profit Margin 58.45% 54.19%
Selling, General & Admin $320.0M $348.0M
YoY Change -8.05% 91.21%
% of Gross Profit 44.69% 51.71%
Research & Development $81.00M $89.00M
YoY Change -8.99% 32.84%
% of Gross Profit 11.31% 13.22%
Depreciation & Amortization $176.0M $202.0M
YoY Change -12.87% 146.34%
% of Gross Profit 24.58% 30.01%
Operating Expenses $401.0M $437.0M
YoY Change -8.24% 75.5%
Operating Profit $315.0M $236.0M
YoY Change 33.47% 210.53%
Interest Expense $52.00M $61.00M
YoY Change -14.75% 281.25%
% of Operating Profit 16.51% 25.85%
Other Income/Expense, Net -$9.000M $0.00
YoY Change -100.0%
Pretax Income $71.00M -$80.00M
YoY Change -188.75% 17.65%
Income Tax $23.00M -$19.00M
% Of Pretax Income 32.39%
Net Earnings $48.00M -$61.00M
YoY Change -178.69% 24.49%
Net Earnings / Revenue 3.92% -4.91%
Basic Earnings Per Share $0.10 -$0.12
Diluted Earnings Per Share $0.10 -$0.12
COMMON SHARES
Basic Shares Outstanding 488.0M shares 486.7M shares
Diluted Shares Outstanding 492.2M shares 486.7M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $342.0M $515.0M
YoY Change -33.59% -57.3%
Cash & Equivalents $342.0M $515.0M
Short-Term Investments
Other Short-Term Assets $315.0M $273.0M
YoY Change 15.38% 90.91%
Inventory $1.345B $1.424B
Prepaid Expenses
Receivables $973.0M $1.028B
Other Receivables $219.0M $104.0M
Total Short-Term Assets $3.194B $3.344B
YoY Change -4.49% 7.16%
LONG-TERM ASSETS
Property, Plant & Equipment $987.0M $1.271B
YoY Change -22.34% 36.65%
Goodwill $6.116B $6.016B
YoY Change 1.66% 100.27%
Intangibles $5.395B $6.032B
YoY Change -10.56% 145.65%
Long-Term Investments $23.00M $34.00M
YoY Change -32.35% 70.0%
Other Assets $559.0M $325.0M
YoY Change 72.0% 49.77%
Total Long-Term Assets $13.06B $13.64B
YoY Change -4.3% 106.52%
TOTAL ASSETS
Total Short-Term Assets $3.194B $3.344B
Total Long-Term Assets $13.06B $13.64B
Total Assets $16.25B $16.99B
YoY Change -4.34% 74.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $402.0M $411.0M
YoY Change -2.19% 91.16%
Accrued Expenses $111.0M $114.0M
YoY Change -2.63% 103.57%
Deferred Revenue $295.0M $331.0M
YoY Change -10.88% 71.77%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $61.00M $605.0M
YoY Change -89.92% 2226.92%
Total Short-Term Liabilities $1.307B $2.034B
YoY Change -35.74% 187.49%
LONG-TERM LIABILITIES
Long-Term Debt $6.073B $5.556B
YoY Change 9.31% 172.94%
Other Long-Term Liabilities $242.0M $247.0M
YoY Change -2.02% 64.34%
Total Long-Term Liabilities $6.315B $5.803B
YoY Change 8.82% 165.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.307B $2.034B
Total Long-Term Liabilities $6.315B $5.803B
Total Liabilities $8.639B $8.981B
YoY Change -3.81% 192.95%
SHAREHOLDERS EQUITY
Retained Earnings -$901.0M -$538.0M
YoY Change 67.47% -1691.72%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.612B $8.007B
YoY Change
Total Liabilities & Shareholders Equity $16.25B $16.99B
YoY Change -4.34% 74.64%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $48.00M -$61.00M
YoY Change -178.69% 24.49%
Depreciation, Depletion And Amortization $176.0M $202.0M
YoY Change -12.87% 146.34%
Cash From Operating Activities -$62.00M $22.00M
YoY Change -381.82% 450.0%
INVESTING ACTIVITIES
Capital Expenditures $19.00M $18.00M
YoY Change 5.56% 38.46%
Acquisitions $0.00 -$73.00M
YoY Change -100.0%
Other Investing Activities $3.000M $7.000M
YoY Change -57.14%
Cash From Investing Activities -$29.00M $10.00M
YoY Change -390.0% -150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$200.0M $2.000M
YoY Change -10100.0% -99.78%
NET CHANGE
Cash From Operating Activities -$62.00M $22.00M
Cash From Investing Activities -$29.00M $10.00M
Cash From Financing Activities -$200.0M $2.000M
Net Change In Cash -$296.0M $9.000M
YoY Change -3388.89% -98.97%
FREE CASH FLOW
Cash From Operating Activities -$62.00M $22.00M
Capital Expenditures $19.00M $18.00M
Free Cash Flow -$81.00M $4.000M
YoY Change -2125.0% -144.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001739104
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q1 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
http://fasb.org/us-gaap/2021-01-31#PensionPlansDefinedBenefitMember
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38661
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Elanco Animal Health Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IN
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46140
CY2022Q1 dei City Area Code
CityAreaCode
877
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
352-6261
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5497352
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2500 INNOVATION WAY
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
GREENFIELD
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
474096131 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1225000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1242000000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
509000000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
569000000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
147000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81000000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89000000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
320000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
348000000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
137000000 USD
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
46000000 USD
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
108000000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
52000000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
61000000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9000000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
1154000000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1322000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-61000000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
488000000.0 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
486700000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492200000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
486700000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-61000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
109000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
53000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-85000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-466000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-8000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-405000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-466000000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
342000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
638000000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
973000000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
833000000 USD
CY2022Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
219000000 USD
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
195000000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1345000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1373000000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
315000000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
237000000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3194000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3276000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
6116000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
6172000000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5395000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5587000000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
559000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
387000000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
670000000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1041000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
987000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1061000000 USD
CY2022Q1 us-gaap Assets
Assets
16251000000 USD
CY2021Q4 us-gaap Assets
Assets
16483000000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111000000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
185000000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
747000000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
745000000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
402000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
418000000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
295000000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
316000000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
61000000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
294000000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
438000000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
430000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1307000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1643000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6073000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6025000000 USD
CY2022Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
270000000 USD
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
271000000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
242000000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
261000000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
8639000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
8945000000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
474091024 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
474091024 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
473119786 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
473119786 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8699000000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8696000000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-901000000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-949000000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-186000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-209000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7612000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7538000000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16251000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16483000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8476000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-61000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-405000000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
18000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
8007000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7538000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23000000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000000 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7612000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-61000000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
202000000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11000000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32000000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15000000 USD
CY2022Q1 elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
28000000 USD
CY2021Q1 elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
9000000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-1000000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 USD
CY2022Q1 elan Business Combination Inventories Step Up Fair Value Adjustment
BusinessCombinationInventoriesStepUpFairValueAdjustment
0 USD
CY2021Q1 elan Business Combination Inventories Step Up Fair Value Adjustment
BusinessCombinationInventoriesStepUpFairValueAdjustment
62000000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
331000000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
183000000 USD
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
13000000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
10000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22000000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-73000000 USD
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
33000000 USD
CY2022Q1 us-gaap Payments For Software
PaymentsForSoftware
7000000 USD
CY2021Q1 us-gaap Payments For Software
PaymentsForSoftware
5000000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3000000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10000000 USD
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
63000000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
150000000 USD
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
89000000 USD
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
20000000 USD
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
163000000 USD
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
100000000 USD
CY2022Q1 elan Proceeds From Payments To Transactions With Parent
ProceedsFromPaymentsToTransactionsWithParent
0 USD
CY2021Q1 elan Proceeds From Payments To Transactions With Parent
ProceedsFromPaymentsToTransactionsWithParent
-11000000 USD
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-200000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-25000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-296000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
638000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
506000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
515000000 USD
CY2022Q1 elan Number Of Brands In Entitys Portfolio
NumberOfBrandsInEntitysPortfolio
200 country
CY2022Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
90 country
CY2022Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. Basis of Presentation and Summary of Significant Accounting Policies</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited condensed consolidated financial statements in accordance with the U.S. Securities and Exchange Commission (SEC) requirements for interim reporting. As permitted under those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been condensed or omitted. The information included in this Form 10-Q should be read in conjunction with our consolidated financial statements and accompanying notes for the year ended December 31, 2021 included in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1739104/000173910422000005/elan-20211231.htm" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the SEC on February 28, 2022. In addition, results for interim periods should not be considered indicative of results for any other interim period or for the full year ending December 31, 2022 or any other future period. </span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for fair presentation of the results of operations for the periods shown. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. Certain reclassifications of prior year information have been made to conform to the current year's presentation.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies set forth in Note 3 to the consolidated financial statements in our Annual Report on </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1739104/000173910422000005/elan-20211231.htm" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the year ended December 31, 2021 appropriately represent, in all material respects, the current status of our accounting policies, except as it relates to the adoption of the standard that was effective January 1, 2022 as described in Note 3: Implementation of New Financial Accounting Pronouncements.</span></div>
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
316000000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
295000000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
219000000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
182000000 USD
CY2022Q1 elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
240000000 USD
CY2021Q1 elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
146000000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
295000000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
331000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1225000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1242000000 USD
CY2022Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
55000000 USD
CY2021 elan Number Of Restructuring Programs Announced
NumberOfRestructuringProgramsAnnounced
2 restructuringProgram
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
-7000000 USD
CY2021Q1 us-gaap Severance Costs1
SeveranceCosts1
26000000 USD
CY2022Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
1000000 USD
CY2021Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
0 USD
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
24000000 USD
CY2021Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
81000000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
23000000 USD
CY2022Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2021Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
9000000 USD
CY2022Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
28000000 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
2000000 USD
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
0 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-9000000 USD
CY2022Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2021Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
1000000 USD
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
46000000 USD
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
108000000 USD
CY2022Q1 elan Restructuring Expected Payment Term
RestructuringExpectedPaymentTerm
P12M
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
22000000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
603000000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
598000000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
572000000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
565000000 USD
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
219000000 USD
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
256000000 USD
CY2022Q1 us-gaap Inventory Gross
InventoryGross
1394000000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
1419000000 USD
CY2022Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
49000000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
46000000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1345000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1373000000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
78000000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
82000000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
6134000000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
6319000000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
61000000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
294000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6073000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6025000000 USD
CY2021Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2000000 USD
CY2022Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
47000000 USD
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3000000 USD
CY2021Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-7000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19000000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.321
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.321
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19000000 USD
CY2020Q4 elan Loss Contingency Percent Of Te Us Issued Involved In Lawsuit
LossContingencyPercentOfTEUsIssuedInvolvedInLawsuit
0.0500
CY2021Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2022Q1 elan Lessee Operating Lease Lease Not Yet Commenced Liability To Be Paid
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityToBePaid
310000000 USD
CY2022Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P25Y
CY2022Q1 elan Tax Incremental Financing Estimated Total Incentive To Be Funded
TaxIncrementalFinancingEstimatedTotalIncentiveToBeFunded
64000000 USD
CY2021Q4 elan Tax Incremental Financing Commitment Amount
TaxIncrementalFinancingCommitmentAmount
64000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1225000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1242000000 USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4400000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
48000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-61000000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
488000000.0 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
486700000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4200000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492200000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
486700000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares

Files In Submission

Name View Source Status
0001739104-22-000010-index-headers.html Edgar Link pending
0001739104-22-000010-index.html Edgar Link pending
0001739104-22-000010.txt Edgar Link pending
0001739104-22-000010-xbrl.zip Edgar Link pending
elan-20220331.htm Edgar Link pending
elan-20220331.xsd Edgar Link pending
elan-20220331_cal.xml Edgar Link unprocessable
elan-20220331_def.xml Edgar Link unprocessable
elan-20220331_g1.jpg Edgar Link pending
elan-20220331_htm.xml Edgar Link completed
elan-20220331_lab.xml Edgar Link unprocessable
elan-20220331_pre.xml Edgar Link unprocessable
ex311elanco-20220331xceoce.htm Edgar Link pending
ex312elanco-20220331xcfoce.htm Edgar Link pending
ex32elanco-20220331xsectio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending